Walleye Trading’s Filana Therapeutics FLNA Stock Holding History

Walleye Trading’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.13K	Sell	947 -20,021	-95%	-$28.5K	﹤0.01%	3899
2026 Q1	$35.4K	Buy	20,968 +11,790	+128%	+$24.3K	﹤0.01%	3759
2025 Q4	$18.2K	Sell	9,178 -26,475	-74%	-$84.8K	﹤0.01%	4115
2025 Q3	$104K	Buy	35,653 +16,484	+86%	+$37.9K	﹤0.01%	3700
2025 Q2	$34.7K	Sell	19,169 -23,726	-55%	-$42.2K	﹤0.01%	3893
2025 Q1	$64.3K	Buy	+42,895	New	+$108K	﹤0.01%	3543
2024 Q3	–	Sell	-3,985	Closed	-$91.8K	–	4522
2024 Q2	$49.2K	Buy	+3,985	New	+$84K	﹤0.01%	3593
2023 Q3	–	Sell	-27,009	Closed	-$535K	–	5315
2023 Q2	$662K	Buy	+27,009	New	+$650K	﹤0.01%	2527
2021 Q2	–	Sell	-348	Closed	-$18.6K	–	5498
2021 Q1	$16K	Buy	+348	New	+$13.7K	﹤0.01%	4588
2016 Q3	–	Sell	-214	Closed	-$3K	–	5349
2016 Q2	$3K	Buy	+214	New	+$3.39K	﹤0.01%	5075

Other funds holding FLNA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Walleye Trading's FLNA Position: Q2 2026 in Review

Walleye Trading reduced its Filana Therapeutics (FLNA) stake by 95% in Q2 2026, selling an estimated $28.5K and leaving 947 shares worth $1.13K. The position accounts for ﹤0.01% of the portfolio, ranked #3899.

Walleye Trading first reported a position in FLNA in Q2 2016 and has held it in 10 quarters since. The position peaked at $662K in Q2 2023. 85 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

Walleye Trading held 947 shares of Filana Therapeutics worth $1.13K as of Q2 2026.
Walleye Trading sold 20,021 Filana Therapeutics shares in Q2 2026, an estimated $28.5K.
Filana Therapeutics made up ﹤0.01% of Walleye Trading's portfolio in Q2 2026, its #3899 holding.
Walleye Trading first reported a position in Filana Therapeutics in Q2 2016 and has held it in 10 quarters since.
Walleye Trading's Filana Therapeutics position peaked at $662K in Q2 2023.
85 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.